Scientists check if Real-World records can mimic Gold-Standard cancer trial
NCT ID NCT07274709
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether information from routine medical records (real-world data) can produce the same results as a carefully controlled clinical trial called MONALEESA-2 for advanced breast cancer. Researchers analyzed data from over 2,400 patients to see if they could reliably measure survival times. The goal is to learn when real-world data can be trusted for future research, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02120, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Can a pill combo outpace chemotherapy for aggressive breast cancer?
- Could a personal coach at home boost energy for cancer patients?
- Can an immune booster help chemotherapy fight metastatic breast cancer?